0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
INFLUENTIAL PUBLICATIONS   |    
Bibliography Panic and Social Anxiety Disorder
FOCUS 2008;6:459-461.

This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.

Abstract Teaser
Figures in this Article

Pollack MH, Otto MW, Roy-Byrne P, Coplan JD, Rothbaum BO, Simon NM, Gorman JM: Novel treatment approaches for refractory anxiety disorders. Depress Anxiety 2008; 25: 467— 76
[PubMed]
[CrossRef]
 
Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK, Stein MB: Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008; 30: 208— 225
[PubMed]
[CrossRef]
 
Stein MB, Goin MK, Pollack MH, Roy-Byrne P, Sareen J, Simon NM, Campbell-Sills L: American Psychiatric Association Work Group on Panic Disorder. Practice guideline for the treatment of patients with panic disorder, second edition.  Am J Psychiatry (in press)
 
Batelaan N, de Graaf R, Van Balkom A, Vollebergh W, Beekman A: Thresholds for health and thresholds for illness: panic disorder versus subthreshold panic disorder.  Psychol Med 2007; 37: 247— 56
[PubMed]
[CrossRef]
 
Boden JM, Fergusson DM, Horwood LJ: Anxiety disorders and suicidal behaviours in adolescence and young adulthood: findings from a longitudinal study.  Psychol Med 2007; 37: 431— 440
[PubMed]
[CrossRef]
 
Connolly SD, Bernstein GA: Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders.  J Am Acad Child Adolesc Psychiatry 2007; 46: 267— 283
[PubMed]
[CrossRef]
 
Craske MG, Farchione TJ, Allen LB, Barrios V, Stoyanova M, Rose R: Cognitive behavioral therapy for panic disorder and comorbidity: more of the same or less of more? Behav Res Ther 2007; 45: 1095— 1109
[PubMed]
[CrossRef]
 
Etkin A, Wager TD: Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia.  Am J Psychiatry . 2007; 164: 1476— 1488
[PubMed]
[CrossRef]
 
Furukawa TA, Watanabe N, Churchill R: Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia.  Cochrane Database Syst Rev 2007: CD004364
 
Milrod B, Leon AC, Busch F, Rudden M, Schwalberg M, Clarkin J, Aronson A, Singer M, Turchin W, Klass ET, Graf E, Teres JJ, Shear MK: A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. Am J Psychiatry 2007; 164: 265— 272
[PubMed]
[CrossRef]
 
Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B: A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.  Depress Anxiety 2007; 24: 1— 14
[PubMed]
[CrossRef]
 
Siev J, Chambless DL: Specificity of treatment effects: cognitive therapy and relaxation for generalized anxiety and panic disorders.  J Consult Clin Psychol 2007; 75: 513— 522
[PubMed]
[CrossRef]
 
Watanabe N, Churchill R, Furukawa TA: Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review.  BMC Psychiatry 2007; 7: 18
[PubMed]
[CrossRef]
 
Bystritsky A: Treatment-resistant anxiety disorders.  Mol Psychiatry 2006; 11: 805— 814
[PubMed]
[CrossRef]
 
Carlbring P, Bohman S, Brunt S, Buhrman M, Westling BE, Ekselius L, Andersson G: Remote treatment of panic disorder: a randomized trial of internet-based cognitive behavior therapy supplemented with telephone calls.  Am J Psychiatry 2006; 163: 2119— 2125
[PubMed]
[CrossRef]
 
Conway KP, Compton W, Stinson FS, Grant BF: Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.  J Clin Psychiatry 2006; 67: 247— 257
[PubMed]
[CrossRef]
 
Furukawa TA, Watanabe N, Churchill R: Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. Br J Psychiatry 2006; 188: 305— 312
[PubMed]
[CrossRef]
 
Goodwin RD, Roy-Byrne P: Panic and suicidal ideation and suicide attempts: results from the National Comorbidity Survey.  Depress Anxiety 2006; 23: 124— 132
[PubMed]
[CrossRef]
 
Heldt E, Gus Manfro G, Kipper L, Blaya C, Isolan L, Otto MW: One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcome and predictors of remission.  Behav Res Ther 2006; 44: 657— 665
[PubMed]
[CrossRef]
 
Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters E: The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication.  Arch Gen Psychiatry 2006; 63: 415— 424
[PubMed]
[CrossRef]
 
Katon WJ: Clinical practice: panic disorder.  N Engl J Med 2006; 354: 2360— 2367
[PubMed]
[CrossRef]
 
Paulus MP, Stein, MB: An insular view of anxiety.  Biol Psychiatry 2006; 60: 383— 387
[PubMed]
[CrossRef]
 
Ross, LE, McLean LM: Anxiety disorders during pregnancy and the postpartum period: a systematic review.  J Clin Psychiatry 2006; 67: 1285— 1298
[PubMed]
[CrossRef]
 
Roy-Byrne P, Craske M, Stein M: Panic disorder.  Lancet 2006; 368: 1023— 1032
[PubMed]
[CrossRef]
 
Sareen J, Chartier M, Paulus MP, Stein MB: Illicit drug use and anxiety disorders: findings from two community surveys.  Psychiatry Res 2006; 142: 11— 17
[PubMed]
[CrossRef]
 
Schraufnagel TJ, Wagner AW, Miranda J, Roy-Byrne PP: Treating minority patients with depression and anxiety: what does the evidence tell us. Gen Hosp Psychiatry 2006; 28: 27— 36
[PubMed]
[CrossRef]
 
Westra H, Dozois D: Preparing clients for cognitive behavior therapy: a randomized pilot study of motivational interviewing for anxiety.  Cogn Ther Res 2006; 30: 481— 498
[CrossRef]
 
Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB: Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005; 162: 1179— 1187
[PubMed]
[CrossRef]
 
Carlbring P, Nilsson-Ihrfelt E, Waara J, Kollenstam C, Buhrman M, Kaldo V, Söderberg M, Ekselius L, Andersson G: Treatment of panic disorder: live therapy vs. self-help via the Internet.  Behav Res Ther 2005; 43: 1321— 1333
[PubMed]
[CrossRef]
 
Flint A: Anxiety and its disorders in late life: moving the field forward.  Am J Geriatric Psychiatry 2005; 13: 3— 6
 
Hettema JM, Prescott CA, Meyers JM, Neale MC, Kendler KS: The structure of genetic and environmental risk factors for anxiety disorders in men and women.  Arch Gen Psychiatry 2005; 62: 182— 189
[PubMed]
[CrossRef]
 
Mitte K: A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia.  J Affect Disord 2005; 88: 27— 45
[PubMed]
[CrossRef]
 
Roy-Byrne PP, Craske MG, Stein MB, Sullivan G, Bystritsky A, Katon W, Golinelli D, Sherbourne CD: A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder.  Arch Gen Psychiatry 2005; 62: 290— 298
[PubMed]
[CrossRef]
 
Smoller JW, Yamaki LH, Fagerness JA, Biederman J, Racette S, Laird NM, Kagan J, Snidman N, Faraone SV, Hirshfeld-Becker D, Tsuang MT, Slaugenhaupt SA, Rosenbaum JF, Sklar PB: The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder.  Biol Psychiatry 2005; 57: 1485— 1492
[PubMed]
[CrossRef]
 
Biederman J, Petty C, Faraone SV, Hirshfeld-Becker D, Pollack MH, Henin A, Gilbert J, Rosenbaum JF: Moderating effects of major depression on patterns of comorbidity in patients with panic disorder.  Psychiatry Res 2004; 14: 126, 143— 149
 
Deacon BJ, Abramowitz JS: Cognitive and behavioral treatments for anxiety disorders: a review of meta-analytic findings. J Clin Psychol 2004; 160: 429— 441
 
National Institute for Clinical Excellence: Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. 2004. http://www.nice.org.uk/CG022quickrefguide
 
Sheikh JI, Swales PJ, Carlson EB, Lindley SE: Aging and panic disorder: phenomenology, comorbidity, and risk factors.  Am J Geriatr Psychiatry 2004; 12: 102— 109
[PubMed]
 
Fleet RP, Lavoie KL, Martel JP, Dupuis G, Marchand A, Beitman BD: Two-year follow-up status of emergency department patients with chest pain: was it panic disorder?  CJEM 2003; 5: 247— 254
[PubMed]
 
Lewis-Fernandez R, Guarnaccia PJ, Martinez IE, Salman E, Schmidt A, Liebowitz M: Comparative phenomenology of ataques de nervios, panic attacks, and panic disorder.  Cult Med Psychiatry 2002; 26: 199— 223
[PubMed]
[CrossRef]
 
Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D: Early coadministration of clonazepam with sertraline for panic disorder.  Arch Gen Psychiatry 2001; 58: 681— 686
[PubMed]
[CrossRef]
 
Katzelnick DJ, Kobak KA, DeLeire T, Henk HJ, Greist JH, Davidson JR, Schneier FR, Stein MB, Helstad CP: Impact of generalized social anxiety disorder in managed care.  Am J Psychiatry 2001; 158: 1999— 2007
[PubMed]
[CrossRef]
 
Fleet RP, Marchand A, Dupuis G, Kaczorowski J, Beitman BD: Comparing emergency department and psychiatric setting patients with panic disorder.  Psychosomatics 1998; 39: 512— 518
[PubMed]
 
Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, Gorman JM, Papp LA: Multicenter collaborative Panic Disorder Severity Scale.  Am J Psychiatry 1997; 154: 1571— 1575
[PubMed]
 
Nagy LM, Krystal JH, Woods SW, Charney DS: Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.  Arch Gen Psychiatry 1989; 46: 993— 999
[PubMed]
 
Klein DF: Delineation of two drug-responsive anxiety syndromes.  Psychopharmacologia 1964; 5: 397— 408
[PubMed]
[CrossRef]
 
Klein DF, Fink M: Psychiatric reaction patterns to imipramine. Am J Psychiatry 1962; 119: 432— 438
[PubMed]
 
References Container
Mörtberg E, Clark DM, Sundin O, Aberg Wistedt A. Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: a randomized controlled trial.  Acta Psychiatr Scand 2007; 115: 142— 154
[PubMed]
[CrossRef]
 
Sareen J, Campbell DW, Leslie WD, Malisza KL, Stein MB, Paulus MP, Kravetsky LB, Kjernisted KD, Walker JR, Reiss JP: Striatal function in generalized social phobia: a functional magnetic resonance imaging study.  Biol Psychiatry 2007; 61: 396— 404
[PubMed]
[CrossRef]
 
Foa EB: Social anxiety disorder treatments: psychosocial therapies.  J Clin Psychiatry 2006; 67( suppl 12): 27— 30
 
Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW: Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.  Arch Gen Psychiatry 2006; 63: 298— 304
[PubMed]
[CrossRef]
 
Matthew SJ, Ho S: Etiology and neurobiology of social anxiety disorder.  J Clin Psychiatry 2006; 67( suppl 12): 9— 13
[CrossRef]
 
Phan KL, Fitzgerald DA, Nathan PJ, Tancer ME: Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia.  Biol Psychiatry 2006; 59: 424— 429
[PubMed]
[CrossRef]
 
Stein MB: An epidemiologic perspective on social anxiety disorder.  J Clin Psychiatry 2006; 67( suppl 12): 3— 8
[CrossRef]
 
Liebowitz MR, Mangano RM, Bradwejn J, Asnis G, SAD Study Group: A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.  J Clin Psychiatry 2005; 66: 238— 247
[PubMed]
[CrossRef]
 
Mancini C, Van Ameringen M, Bennett M, Patterson B, Watson C: Emerging treatments for child and adolescent social phobia: a review.  J Child Adolesc Psychopharmacol 2005; 15: 589— 607
[PubMed]
[CrossRef]
 
Bögels SM, Mansell W: Attention processes in the maintenance and treatment of social phobia: hypervigilance, avoidance and self-focused attention.  Clin Psychol Rev . 2004; 24: 827— 856
[PubMed]
[CrossRef]
 
Van Ameringen M, Mancini C, Pipe B, Oakman J, Bennett M: An open trial of topiramate in the treatment of generalized social phobia.  J Clin Psychiatry 2004; 65: 1674— 1678
[PubMed]
[CrossRef]
 
Heimberg RG: Cognitive-behavioral therapy for social anxiety disorder: current status and future directions.  Biol Psychiatry 2002; 51: 101— 108
[PubMed]
[CrossRef]
 
Stein MB, Kean YM: Disability and quality of life in social phobia: epidemiologic findings.  Am J Psychiatry 2000; 157: 1606— 1613
[PubMed]
[CrossRef]
 
Liebowitz MR, Heimberg RG, Schneier FR, Hope DA, Davies S, Holt CS, Goetz D, Juster HR, Lin SH, Bruch MA, Marshall RD, Klein DF: Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome.  Depress Anxiety 1999; 10: 89— 98
[PubMed]
[CrossRef]
 
Kessler RC, Berglund P: Social phobia subtypes in the National Comorbidity Survey.  Am J Psychiatry 1998; 155: 613— 619
[PubMed]
 
Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF: Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome.  Arch Gen Psychiatry 1998; 55: 1133— 1141
[PubMed]
[CrossRef]
 
Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman J, Papp L, Davies S, Gully R: Phenelzine vs atenolol in social phobia; a placebo-controlled comparison.  Arch Gen Psychiatry 1992; 49: 290— 300
[PubMed]
 
References Container
+

References

Pollack MH, Otto MW, Roy-Byrne P, Coplan JD, Rothbaum BO, Simon NM, Gorman JM: Novel treatment approaches for refractory anxiety disorders. Depress Anxiety 2008; 25: 467— 76
[PubMed]
[CrossRef]
 
Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK, Stein MB: Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008; 30: 208— 225
[PubMed]
[CrossRef]
 
Stein MB, Goin MK, Pollack MH, Roy-Byrne P, Sareen J, Simon NM, Campbell-Sills L: American Psychiatric Association Work Group on Panic Disorder. Practice guideline for the treatment of patients with panic disorder, second edition.  Am J Psychiatry (in press)
 
Batelaan N, de Graaf R, Van Balkom A, Vollebergh W, Beekman A: Thresholds for health and thresholds for illness: panic disorder versus subthreshold panic disorder.  Psychol Med 2007; 37: 247— 56
[PubMed]
[CrossRef]
 
Boden JM, Fergusson DM, Horwood LJ: Anxiety disorders and suicidal behaviours in adolescence and young adulthood: findings from a longitudinal study.  Psychol Med 2007; 37: 431— 440
[PubMed]
[CrossRef]
 
Connolly SD, Bernstein GA: Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders.  J Am Acad Child Adolesc Psychiatry 2007; 46: 267— 283
[PubMed]
[CrossRef]
 
Craske MG, Farchione TJ, Allen LB, Barrios V, Stoyanova M, Rose R: Cognitive behavioral therapy for panic disorder and comorbidity: more of the same or less of more? Behav Res Ther 2007; 45: 1095— 1109
[PubMed]
[CrossRef]
 
Etkin A, Wager TD: Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia.  Am J Psychiatry . 2007; 164: 1476— 1488
[PubMed]
[CrossRef]
 
Furukawa TA, Watanabe N, Churchill R: Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia.  Cochrane Database Syst Rev 2007: CD004364
 
Milrod B, Leon AC, Busch F, Rudden M, Schwalberg M, Clarkin J, Aronson A, Singer M, Turchin W, Klass ET, Graf E, Teres JJ, Shear MK: A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. Am J Psychiatry 2007; 164: 265— 272
[PubMed]
[CrossRef]
 
Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B: A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.  Depress Anxiety 2007; 24: 1— 14
[PubMed]
[CrossRef]
 
Siev J, Chambless DL: Specificity of treatment effects: cognitive therapy and relaxation for generalized anxiety and panic disorders.  J Consult Clin Psychol 2007; 75: 513— 522
[PubMed]
[CrossRef]
 
Watanabe N, Churchill R, Furukawa TA: Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review.  BMC Psychiatry 2007; 7: 18
[PubMed]
[CrossRef]
 
Bystritsky A: Treatment-resistant anxiety disorders.  Mol Psychiatry 2006; 11: 805— 814
[PubMed]
[CrossRef]
 
Carlbring P, Bohman S, Brunt S, Buhrman M, Westling BE, Ekselius L, Andersson G: Remote treatment of panic disorder: a randomized trial of internet-based cognitive behavior therapy supplemented with telephone calls.  Am J Psychiatry 2006; 163: 2119— 2125
[PubMed]
[CrossRef]
 
Conway KP, Compton W, Stinson FS, Grant BF: Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.  J Clin Psychiatry 2006; 67: 247— 257
[PubMed]
[CrossRef]
 
Furukawa TA, Watanabe N, Churchill R: Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. Br J Psychiatry 2006; 188: 305— 312
[PubMed]
[CrossRef]
 
Goodwin RD, Roy-Byrne P: Panic and suicidal ideation and suicide attempts: results from the National Comorbidity Survey.  Depress Anxiety 2006; 23: 124— 132
[PubMed]
[CrossRef]
 
Heldt E, Gus Manfro G, Kipper L, Blaya C, Isolan L, Otto MW: One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcome and predictors of remission.  Behav Res Ther 2006; 44: 657— 665
[PubMed]
[CrossRef]
 
Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters E: The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication.  Arch Gen Psychiatry 2006; 63: 415— 424
[PubMed]
[CrossRef]
 
Katon WJ: Clinical practice: panic disorder.  N Engl J Med 2006; 354: 2360— 2367
[PubMed]
[CrossRef]
 
Paulus MP, Stein, MB: An insular view of anxiety.  Biol Psychiatry 2006; 60: 383— 387
[PubMed]
[CrossRef]
 
Ross, LE, McLean LM: Anxiety disorders during pregnancy and the postpartum period: a systematic review.  J Clin Psychiatry 2006; 67: 1285— 1298
[PubMed]
[CrossRef]
 
Roy-Byrne P, Craske M, Stein M: Panic disorder.  Lancet 2006; 368: 1023— 1032
[PubMed]
[CrossRef]
 
Sareen J, Chartier M, Paulus MP, Stein MB: Illicit drug use and anxiety disorders: findings from two community surveys.  Psychiatry Res 2006; 142: 11— 17
[PubMed]
[CrossRef]
 
Schraufnagel TJ, Wagner AW, Miranda J, Roy-Byrne PP: Treating minority patients with depression and anxiety: what does the evidence tell us. Gen Hosp Psychiatry 2006; 28: 27— 36
[PubMed]
[CrossRef]
 
Westra H, Dozois D: Preparing clients for cognitive behavior therapy: a randomized pilot study of motivational interviewing for anxiety.  Cogn Ther Res 2006; 30: 481— 498
[CrossRef]
 
Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB: Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005; 162: 1179— 1187
[PubMed]
[CrossRef]
 
Carlbring P, Nilsson-Ihrfelt E, Waara J, Kollenstam C, Buhrman M, Kaldo V, Söderberg M, Ekselius L, Andersson G: Treatment of panic disorder: live therapy vs. self-help via the Internet.  Behav Res Ther 2005; 43: 1321— 1333
[PubMed]
[CrossRef]
 
Flint A: Anxiety and its disorders in late life: moving the field forward.  Am J Geriatric Psychiatry 2005; 13: 3— 6
 
Hettema JM, Prescott CA, Meyers JM, Neale MC, Kendler KS: The structure of genetic and environmental risk factors for anxiety disorders in men and women.  Arch Gen Psychiatry 2005; 62: 182— 189
[PubMed]
[CrossRef]
 
Mitte K: A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia.  J Affect Disord 2005; 88: 27— 45
[PubMed]
[CrossRef]
 
Roy-Byrne PP, Craske MG, Stein MB, Sullivan G, Bystritsky A, Katon W, Golinelli D, Sherbourne CD: A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder.  Arch Gen Psychiatry 2005; 62: 290— 298
[PubMed]
[CrossRef]
 
Smoller JW, Yamaki LH, Fagerness JA, Biederman J, Racette S, Laird NM, Kagan J, Snidman N, Faraone SV, Hirshfeld-Becker D, Tsuang MT, Slaugenhaupt SA, Rosenbaum JF, Sklar PB: The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder.  Biol Psychiatry 2005; 57: 1485— 1492
[PubMed]
[CrossRef]
 
Biederman J, Petty C, Faraone SV, Hirshfeld-Becker D, Pollack MH, Henin A, Gilbert J, Rosenbaum JF: Moderating effects of major depression on patterns of comorbidity in patients with panic disorder.  Psychiatry Res 2004; 14: 126, 143— 149
 
Deacon BJ, Abramowitz JS: Cognitive and behavioral treatments for anxiety disorders: a review of meta-analytic findings. J Clin Psychol 2004; 160: 429— 441
 
National Institute for Clinical Excellence: Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. 2004. http://www.nice.org.uk/CG022quickrefguide
 
Sheikh JI, Swales PJ, Carlson EB, Lindley SE: Aging and panic disorder: phenomenology, comorbidity, and risk factors.  Am J Geriatr Psychiatry 2004; 12: 102— 109
[PubMed]
 
Fleet RP, Lavoie KL, Martel JP, Dupuis G, Marchand A, Beitman BD: Two-year follow-up status of emergency department patients with chest pain: was it panic disorder?  CJEM 2003; 5: 247— 254
[PubMed]
 
Lewis-Fernandez R, Guarnaccia PJ, Martinez IE, Salman E, Schmidt A, Liebowitz M: Comparative phenomenology of ataques de nervios, panic attacks, and panic disorder.  Cult Med Psychiatry 2002; 26: 199— 223
[PubMed]
[CrossRef]
 
Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D: Early coadministration of clonazepam with sertraline for panic disorder.  Arch Gen Psychiatry 2001; 58: 681— 686
[PubMed]
[CrossRef]
 
Katzelnick DJ, Kobak KA, DeLeire T, Henk HJ, Greist JH, Davidson JR, Schneier FR, Stein MB, Helstad CP: Impact of generalized social anxiety disorder in managed care.  Am J Psychiatry 2001; 158: 1999— 2007
[PubMed]
[CrossRef]
 
Fleet RP, Marchand A, Dupuis G, Kaczorowski J, Beitman BD: Comparing emergency department and psychiatric setting patients with panic disorder.  Psychosomatics 1998; 39: 512— 518
[PubMed]
 
Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, Gorman JM, Papp LA: Multicenter collaborative Panic Disorder Severity Scale.  Am J Psychiatry 1997; 154: 1571— 1575
[PubMed]
 
Nagy LM, Krystal JH, Woods SW, Charney DS: Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.  Arch Gen Psychiatry 1989; 46: 993— 999
[PubMed]
 
Klein DF: Delineation of two drug-responsive anxiety syndromes.  Psychopharmacologia 1964; 5: 397— 408
[PubMed]
[CrossRef]
 
Klein DF, Fink M: Psychiatric reaction patterns to imipramine. Am J Psychiatry 1962; 119: 432— 438
[PubMed]
 
References Container
Mörtberg E, Clark DM, Sundin O, Aberg Wistedt A. Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: a randomized controlled trial.  Acta Psychiatr Scand 2007; 115: 142— 154
[PubMed]
[CrossRef]
 
Sareen J, Campbell DW, Leslie WD, Malisza KL, Stein MB, Paulus MP, Kravetsky LB, Kjernisted KD, Walker JR, Reiss JP: Striatal function in generalized social phobia: a functional magnetic resonance imaging study.  Biol Psychiatry 2007; 61: 396— 404
[PubMed]
[CrossRef]
 
Foa EB: Social anxiety disorder treatments: psychosocial therapies.  J Clin Psychiatry 2006; 67( suppl 12): 27— 30
 
Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW: Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.  Arch Gen Psychiatry 2006; 63: 298— 304
[PubMed]
[CrossRef]
 
Matthew SJ, Ho S: Etiology and neurobiology of social anxiety disorder.  J Clin Psychiatry 2006; 67( suppl 12): 9— 13
[CrossRef]
 
Phan KL, Fitzgerald DA, Nathan PJ, Tancer ME: Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia.  Biol Psychiatry 2006; 59: 424— 429
[PubMed]
[CrossRef]
 
Stein MB: An epidemiologic perspective on social anxiety disorder.  J Clin Psychiatry 2006; 67( suppl 12): 3— 8
[CrossRef]
 
Liebowitz MR, Mangano RM, Bradwejn J, Asnis G, SAD Study Group: A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.  J Clin Psychiatry 2005; 66: 238— 247
[PubMed]
[CrossRef]
 
Mancini C, Van Ameringen M, Bennett M, Patterson B, Watson C: Emerging treatments for child and adolescent social phobia: a review.  J Child Adolesc Psychopharmacol 2005; 15: 589— 607
[PubMed]
[CrossRef]
 
Bögels SM, Mansell W: Attention processes in the maintenance and treatment of social phobia: hypervigilance, avoidance and self-focused attention.  Clin Psychol Rev . 2004; 24: 827— 856
[PubMed]
[CrossRef]
 
Van Ameringen M, Mancini C, Pipe B, Oakman J, Bennett M: An open trial of topiramate in the treatment of generalized social phobia.  J Clin Psychiatry 2004; 65: 1674— 1678
[PubMed]
[CrossRef]
 
Heimberg RG: Cognitive-behavioral therapy for social anxiety disorder: current status and future directions.  Biol Psychiatry 2002; 51: 101— 108
[PubMed]
[CrossRef]
 
Stein MB, Kean YM: Disability and quality of life in social phobia: epidemiologic findings.  Am J Psychiatry 2000; 157: 1606— 1613
[PubMed]
[CrossRef]
 
Liebowitz MR, Heimberg RG, Schneier FR, Hope DA, Davies S, Holt CS, Goetz D, Juster HR, Lin SH, Bruch MA, Marshall RD, Klein DF: Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome.  Depress Anxiety 1999; 10: 89— 98
[PubMed]
[CrossRef]
 
Kessler RC, Berglund P: Social phobia subtypes in the National Comorbidity Survey.  Am J Psychiatry 1998; 155: 613— 619
[PubMed]
 
Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF: Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome.  Arch Gen Psychiatry 1998; 55: 1133— 1141
[PubMed]
[CrossRef]
 
Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman J, Papp L, Davies S, Gully R: Phenelzine vs atenolol in social phobia; a placebo-controlled comparison.  Arch Gen Psychiatry 1992; 49: 290— 300
[PubMed]
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Articles
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 2.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 6.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 12.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 18.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 12.  >
Topic Collections
Psychiatric News
PubMed Articles